Literature DB >> 8077315

Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.

R Rey1, I Lordereau-Richard, J C Carel, P Barbet, R L Cate, M Roger, J L Chaussain, N Josso.   

Abstract

Anti-Müllerian hormone (AMH), also called Müllerian inhibiting substance or factor, is produced by Sertoli cells from fetal life until puberty. In the present study, AMH, testosterone (T), LH, and FSH were measured by immunochemical methods in the serum of 50 boys with normal or delayed pubertal development, 4 patients with suspected androgen insensitivity, and 11 patients with either central (CPP) or gonadotropin-independent (GIPP) precocious puberty to investigate the hormonal regulatory mechanisms of AMH secretion at puberty. An inverse relationship between AMH and T levels was demonstrated. In boys with normal or delayed puberty with T concentrations below 6.7 nmol/L, AMH values were elevated (mean +/- SEM, 22.4 +/- 3.1 micrograms/L) and widely dispersed. In subjects with T levels over 6.7 nmol/L, AMH levels were uniformly low (3.4 +/- 0.5 micrograms/L), except in patients with suspected androgen insensitivity. No significant relationship was found between AMH and gonadotropin levels. Similar results were obtained in patients with either CPP or GIPP. Longitudinal studies were performed on four boys with CPP and two with GIPP before and after treatment. At the time of diagnosis, the T concentration was high, and AMH levels were usually low in CPP and GIPP patients alike. When appropriate treatment was initiated, the T concentration was normalized within 2-4 weeks, but restoration of prepubertal AMH levels required several months. Mature Sertoli cells were observed in testicular biopsies performed in three patients with untreated GIPP. Our results suggest that gonadotropins are not directly implicated in repression of AMH synthesis at puberty, but, rather, that the decrease in AMH production is the consequence of an androgen-mediated, long term, reversible chain of events leading to morphological and functional maturation of the Sertoli cells. Thus, the fall in serum AMH levels appears to be an excellent marker of Sertoli cell pubertal development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8077315     DOI: 10.1210/jcem.77.5.8077315

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

1.  Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.

Authors:  A M Trbovich; P M Sluss; V M Laurich; F H O'Neill; D T MacLaughlin; P K Donahoe; J Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

2.  Serum Anti-Müllerian Hormone in the Prediction of Response to hCG Stimulation in Children With DSD.

Authors:  Angela K Lucas-Herald; Andreas Kyriakou; Malika Alimussina; Guilherme Guaragna-Filho; Louise A Diver; Ruth McGowan; Karen Smith; Jane D McNeilly; S Faisal Ahmed
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

3.  Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse.

Authors:  L Al-Attar; K Noël; M Dutertre; C Belville; M G Forest; P S Burgoyne; N Josso; R Rey
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 4.  Evaluation of testicular function in prepubertal children.

Authors:  Rosita A Condorelli; Rossella Cannarella; Aldo E Calogero; Sandro La Vignera
Journal:  Endocrine       Date:  2018-07-07       Impact factor: 3.633

Review 5.  Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.

Authors:  David T MacLaughlin; Patricia K Donahoe
Journal:  Future Oncol       Date:  2010-03       Impact factor: 3.404

6.  A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination.

Authors:  Stephan Gasca; Joaquin Canizares; Pascal De Santa Barbara; Catherine Mejean; Francis Poulat; Philippe Berta; Brigitte Boizet-Bonhoure
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

7.  Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development.

Authors:  Kahina Boukari; Geri Meduri; Sylvie Brailly-Tabard; Jean Guibourdenche; Maria Luisa Ciampi; Nathalie Massin; Laetitia Martinerie; Jean-Yves Picard; Rodolfo Rey; Marc Lombès; Jacques Young
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

8.  Testosterone-induced downregulation of anti-Müllerian hormone expression in granulosa cells from small bovine follicles.

Authors:  Nicolás Crisosto; Teresa Sir-Petermann; Monika Greiner; Manuel Maliqueo; Marcela Moreno; Paola Aedo; Hernán E Lara
Journal:  Endocrine       Date:  2009-10       Impact factor: 3.633

9.  Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.

Authors:  R Rey; L al-Attar; F Louis; F Jaubert; P Barbet; C Nihoul-Fékété; J L Chaussain; N Josso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

10.  Persistence and intergenerational transmission of differentially expressed genes in the testes of intracytoplasmic sperm injection conceived mice.

Authors:  Li-ya Wang; Ning Wang; Fang Le; Lei Li; Le-jun Li; Xiao-zhen Liu; Ying-ming Zheng; Hang-ying Lou; Xiang-rong Xu; Xiao-ming Zhu; Yi-min Zhu; He-feng Huang; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2013-05       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.